Private Advisor Group’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$13.5M Buy
155,511
+1,297
+0.8% +$124K 0.06% 320
2025
Q4
$14.8M Buy
154,214
+4,655
+3% +$452K 0.07% 290
2025
Q3
$14.2M Buy
149,559
+46,162
+45% +$4.24M 0.07% 294
2025
Q2
$9.01M Sell
103,397
-2,188
-2% -$186K 0.05% 391
2025
Q1
$9.49M Buy
105,585
+938
+0.9% +$83.9K 0.06% 343
2024
Q4
$8.36M Sell
104,647
-2,720
-3% -$235K 0.05% 374
2024
Q3
$9.67M Sell
107,367
-2,730
-2% -$230K 0.06% 331
2024
Q2
$8.67M Sell
110,097
-2,924
-3% -$240K 0.06% 313
2024
Q1
$9.85M Buy
113,021
+3,175
+3% +$271K 0.07% 264
2023
Q4
$9.05M Sell
109,846
-13,517
-11% -$1.03M 0.07% 273
2023
Q3
$9.66M Buy
123,363
+5,105
+4% +$427K 0.09% 228
2023
Q2
$10.4M Buy
118,258
+9,845
+9% +$848K 0.09% 213
2023
Q1
$8.74M Buy
108,413
+3,107
+3% +$253K 0.08% 234
2022
Q4
$1.93M Sell
105,306
-3,519
-3% -$285K 0.1% 223
2022
Q3
$8.79M Sell
108,825
-28,909
-21% -$2.6M 0.1% 217
2022
Q2
$12.4M Sell
137,734
-38,096
-22% -$3.86M 0.11% 183
2022
Q1
$19.5M Buy
175,830
+26,104
+17% +$2.76M 0.15% 138
2021
Q4
$15.5M Sell
149,726
-101,936
-41% -$11.8M 0.12% 174
2021
Q3
$31.5M Buy
251,662
+133,478
+113% +$17.3M 0.2% 99
2021
Q2
$14.7M Buy
118,184
+8,761
+8% +$1.1M 0.13% 164
2021
Q1
$12.9M Buy
109,423
+56,055
+105% +$6.57M 0.12% 174
2020
Q4
$6.25M Buy
53,368
+9,155
+21% +$1.01M 0.07% 290
2020
Q3
$4.39M Buy
44,213
+644
+1% +$64.7K 0.06% 311
2020
Q2
$4M Buy
43,569
+6,142
+16% +$589K 0.06% 326
2020
Q1
$3.38M Buy
37,427
+5,107
+16% +$543K 0.06% 294
2019
Q4
$3.67M Sell
32,320
-3,677
-10% -$403K 0.06% 347
2019
Q3
$3.91M Buy
35,997
+9,286
+35% +$969K 0.06% 329
2019
Q2
$2.6M Sell
26,711
-2,864
-10% -$261K 0.05% 403
2019
Q1
$2.7M Buy
29,575
+4,440
+18% +$397K 0.05% 349
2018
Q4
$2.29M Sell
25,135
-6,085
-19% -$569K 0.06% 329
2018
Q3
$3.07M Buy
31,220
+4,939
+19% +$457K 0.06% 308
2018
Q2
$2.26M Buy
26,281
+17,035
+184% +$1.42M 0.04% 253
2018
Q1
$744K Sell
9,246
-14,290
-61% -$1.18M 0.03% 522
2017
Q4
$2M Sell
23,536
-12,511
-35% -$1M 0.08% 233
2017
Q3
$2.78M Sell
36,047
-7,198
-17% -$598K 0.07% 286
2017
Q2
$3.77M Buy
43,245
+9,024
+26% +$761K 0.1% 207
2017
Q1
$2.75M Sell
34,221
-1,639
-5% -$128K 0.08% 263
2016
Q4
$2.66M Sell
35,860
-128
-0.4% -$10.1K 0.09% 241
2016
Q3
$3.1M Buy
35,988
+1,306
+4% +$114K 0.13% 173
2016
Q2
$3.03M Buy
34,682
+13,044
+60% +$1.05M 0.12% 172
2016
Q1
$1.61M Sell
21,638
-2,261
-9% -$170K 0.08% 257
2015
Q4
$1.84M Buy
23,899
+421
+2% +$31.7K 0.09% 247
2015
Q3
$1.57M Buy
23,478
+2,874
+14% +$212K 0.09% 259
2015
Q2
$1.53M Buy
20,604
+1,829
+10% +$140K 0.07% 283
2015
Q1
$1.46M Sell
18,775
-4,307
-19% -$326K 0.08% 269
2014
Q4
$1.67M Buy
23,082
+12,462
+117% +$866K 0.11% 236
2014
Q3
$658K Sell
10,620
-15,824
-60% -$1.01M 0.05% 427
2014
Q2
$1.69M Buy
26,444
+18,615
+238% +$1.13M 0.15% 154
2014
Q1
$482K Sell
7,829
-11,621
-60% -$677K 0.05% 421
2013
Q4
$1.12M Buy
+19,450
New +$1.1M 0.12% 197

Other funds holding MDT

Private Advisor Group's MDT Position: Q1 2026 in Review

Private Advisor Group increased its Medtronic (MDT) stake by 0.84% in Q1 2026, buying an estimated $124K and bringing the position to 155,511 shares worth $13.5M. The position accounts for 0.06% of the portfolio, ranked #320.

Private Advisor Group first reported a position in MDT in Q4 2013 and has held it in 50 quarters since. The position peaked at $31.5M in Q3 2021. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Private Advisor Group held 155,511 shares of Medtronic worth $13.5M as of Q1 2026.
  • Private Advisor Group bought 1,297 Medtronic shares in Q1 2026, an estimated $124K.
  • Medtronic made up 0.06% of Private Advisor Group's portfolio in Q1 2026, its #320 holding.
  • Private Advisor Group first reported a position in Medtronic in Q4 2013 and has held it in 50 quarters since.
  • Private Advisor Group's Medtronic position peaked at $31.5M in Q3 2021.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Private Advisor Group's 13F filing for Q1 2026, filed 27 Apr 2026.